Simcere Pharmaceutical Group Ltd. Stock: price and insider trades · Hong Kong

This page follows insider dealings at Simcere Pharmaceutical Group Ltd. as filed with HKEX, a company from the Health Care sector based in Nanjing. In the past year (23 October 2025 to 23 October 2026), 20 filings came from 4 insiders.

The record shows 6 purchases on the open market, made by 2 insiders, against 13 sales by 3 insiders. The totals do not cover 19 filings with an undisclosed amount. A purchase on the market is a deliberate choice to commit personal money, which is why it draws more attention than a grant. The buyers include 2 senior executives.

The last purchase on record was published on 17 June 2026, which is 129 days ago. Typically, a trade is published a median of 6 days after it takes place. Until a filing is published, the market cannot know about the trade. Sales are harder to read than purchases, since they often meet personal needs such as tax or diversification.

For context, the typical company on the same exchange (median of 1,315 companies) published 4 filings over the same period, against 20 filings here. Over the whole record (from 2020), the tally stands at 91 purchases and 48 sales.

Other companies in the same sector with recent insider buying flagged by our signals: Dynavox Group AB and EssilorLuxottica. Source: insider filings from HKEX. Past trades are no guide to future returns.